Wei, Zongsheng et al. published their patent in 2007 |CAS: 23256-42-0

The Article related to antibacterial agent berberine sulfate injection preparation dysentery, Pharmaceuticals: Formulation and Compounding and other aspects.Recommanded Product: 5-(3,4,5-Trimethoxybenzyl)pyrimidine-2,4-diamine 2-hydroxypropanoate

On August 1, 2007, Wei, Zongsheng; Geng, Qiangbin; Guo, Jianhua published a patent.Recommanded Product: 5-(3,4,5-Trimethoxybenzyl)pyrimidine-2,4-diamine 2-hydroxypropanoate The title of the patent was Compounded berberine sulfate injection and its preparation method. And the patent contained the following:

The title injection is composed of berberine sulfate 5-30, mequindox 5-35, trimethoprim lactate 1-25 and atropine 0.5-2 weight parts. The method for preparing the injection comprises dissolving berberine sulfate in hot injection water, stirring to obtain solution A, adding mequindox and niacinamide, stirring to obtain solution B, adding trimethoprim lactate and atropine, stirring, adjusting pH to 4-6 with 10% sulfuric acid, adsorbing with 0.1% activated C for 15-20 min and adding injection water to 1000 weight parts. The experimental process involved the reaction of 5-(3,4,5-Trimethoxybenzyl)pyrimidine-2,4-diamine 2-hydroxypropanoate(cas: 23256-42-0).Recommanded Product: 5-(3,4,5-Trimethoxybenzyl)pyrimidine-2,4-diamine 2-hydroxypropanoate

The Article related to antibacterial agent berberine sulfate injection preparation dysentery, Pharmaceuticals: Formulation and Compounding and other aspects.Recommanded Product: 5-(3,4,5-Trimethoxybenzyl)pyrimidine-2,4-diamine 2-hydroxypropanoate

Referemce:
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia